Publication | Closed Access

The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus

UrologyRenal DiseaseRenal FunctionKidney ResearchMedicineDiabetesType 2PathologyDiabetic Kidney DiseaseNephrologyRenal OutcomesKidney Tubule RemodelingChronic Kidney DiseaseTumor MicroenvironmentExhibits Better Prediction